Stories from Hesse

INFOSYS

Infosys Achieves Binding Corporate Rules Certification from EU Data Protection Authorities

Bengaluru, India (ots/PRNewswire) - - First India-headquartered company to receive BCR certification - An accredited data privacy compliance framework for international data transfers from the EU Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has obtained regulatory approvals for ...

Germany Trade & Invest

Germany Attracts Another Billion-Euro Pharma Project

Berlin (ots) - French pharmaceutical giant Sanofi has confirmed it will invest 1.3 billion euros to expand insulin production in the western German city of Frankfurt am Main. Sanofi says the expansion will encompass around 36,000 square meters – the equivalent of five football fields – on the company’s existing BioCampus site. It will go operational in 2029. The project is being supported by the German national ...

hubergroup Deutschland GmbH

9

Press Release - hubergroup presents an exciting program and product innovations at drupa Touchpoint Packaging 2024 in Düsseldorf

National Research Center for Applied Cybersecurity ATHENE

Severe Vulnerabilities Discovered in Software to Protect Internet Routing

Koehler Group

Koehler Group to Use Power from Its Own Wind Turbines

Koehler Group

Wind Farm Wetzlar-Blasbach Goes Live: Milestone for Sustainable Energy Generation

BIRKENSTOCK Group

BIRKENSTOCK APPOINTS NEW MANAGING DIRECTOR FOR GREATER CHINA: TIFFANY WU TO LEAD AND TO ACCELERATE THE COMPANY’S EXPANSION IN THE GROWTH REGION WITH THE LARGEST UNTAPPED WHITE SPACE POTENTIAL

R-Biopharm AG

Blood Donation Day at R-Biopharm: Employees Help Save Lives

benfovir AG

benfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT)

Darmstadt (ots) - benfovir AG, a German pharmaceutical company focused on developing small molecules against viral infections such as SARS-CoV-2, dengue and herpes virus, today announced that the first part of the Phase 1 clinical trial (BV-01-101/ EudraCT Number: 2021-005616-60.) designed to evaluate the safety, ...

Helaba

3

EXPO REAL: Helaba and Altaal sign green building deal to increase loan to EUR 128 million

R-Biopharm AG

R-Biopharm is IVDR certified

benfovir AG

benfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS

Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...

Helaba

Helaba refinances ”Quartier 205“ for Tishman Speyer in Berlin

Helaba

Lars Hegg appointed as new General Branch Manager of Helaba's Stockholm office

benfovir AG

New therapeutic approach against SARS-CoV-2 successfully tested

Pfungstadt (ots) - - Scientists at the Universities of Frankfurt a.M. and Kent (UK) have identified a metabolic pathway (pentose-phosphate pathway) that is crucial for the propagation of the SARS-CoV-2 virus in human cells. - The compound benfo-oxythiamine, an inhibitor of this metabolic pathway, has succeeded in blocking the replication of the SARS-CoV-2 virus in human cells. - Preclinical testing of this compound has ...

Technische Universität München

How do bacteria build up natural products? X-ray structure analysis gives detailed insights into molecular factory

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36121/ High resolution images: https://mediatum.ub.tum.de/1552301 NEWS RELEASE How do bacteria build ...